[EN] PYRROLO PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CYSTEIN PROTEASES<br/>[FR] PYRROLOPYRIMIDES EN TANT QU'AGENTS D'INHIBITION DE CYSTEINE PROTEASES
申请人:NOVARTIS AG
公开号:WO2003020721A1
公开(公告)日:2003-03-13
The invention provides compounds of Formula I or a pharmaceutically acceptable salt or ester thereof wherein the symbols have meaning as defined, which are inhibitors of cathepsin K and find use pharmaceutically for treatment of diseases and medical conditions in which cathepsin K is implicated, e.g. various disorders including inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors.